Home > Boards > US Listed > Medical - Drugs > Allena Pharmaceuticals Inc (ALNA)

Price target of 10 dollars will be reached

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dinogreeves Member Profile
Member Level 
Followed By 749
Posts 18,063
Boards Moderated 4
Alias Born 01/11/16
160x600 placeholder
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/12/2021 4:03:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2021 2:51:56 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/8/2021 2:14:13 PM
Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 4/8/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/7/2021 9:33:37 AM
Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors GlobeNewswire Inc. - 4/7/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/30/2021 8:18:41 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/30/2021 6:07:02 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/11/2021 7:39:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/11/2021 7:27:16 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/11/2021 7:17:41 AM
Allena Pharmaceuticals EPS misses by $0.05 Seeking Alpha - 3/9/2021 7:35:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/9/2021 7:01:21 AM
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update GlobeNewswire Inc. - 3/9/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2021 4:05:46 PM
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in March GlobeNewswire Inc. - 2/24/2021 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 5:18:40 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/8/2021 10:16:19 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/2/2021 6:20:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2021 6:20:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/2/2021 4:16:56 PM
Allena Pharmaceuticals Appoints Richard D. Katz, M.D. as Chief Financial Officer GlobeNewswire Inc. - 2/2/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/28/2021 5:16:59 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/13/2021 9:03:37 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/6/2021 1:02:39 PM
dinogreeves Member Level  Tuesday, 06/02/20 08:42:32 AM
Re: dinogreeves post# 9
Post # of 58 
Price target of 10 dollars will be reached by mid next week, reasonable cash on hand. Presentation for kidney disorder is only few hours away, once that data is revealed this could jump to 6 dollars instantly with volume.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences